Skip to main content
Premium Trial:

Request an Annual Quote

UK s LGC Gets 2 Million to Develop New Biotech Tools

NEW YORK, July 31-The UK analytical lab service company LGC won more than £2 million in government contracts to develop microarray technology, mass spectrometry methods and other genomic and proteomic research tools, the company said today.


To improve microarray technology, LGC will work with various academic and industrial partners to evaluate the performance and comparability of various microarray systems.


With a £550,000 proteomics grant, LGC researchers will study isotope labeling in mass spectrometry.


Other grants will fund an effort to improve cell-based assays for hepatotoxicity and drug metabolism and a project to validate ultrasound spectroscopy for protein measurement.


The UK Department of Trade and Industry granted these contracts under its Measurements for Biology program, which is designed to improve measurement techniques and standardization in biotechnology.


LGC, based in Teddington, Middlesex, offers analytical and diagnostic lab services for clinical applications and laboratory research.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.